Optimer Announces that the U.S. Food and Drug Administration’s Anti-Infective Drugs A

  • 4. Mai 2011
No Comments

SAN DIEGO, April 5, 2011 /PRNewswire/ — Optimer Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration’s (FDA) Anti-Infective Drugs Advisory Committee (AIDAC) recommended that the FDA approve Optimer’s investigational…

Weiterlesen…
Via (link nur für registrierte Benutzer sichtbar, login oder registriere dich)

  • fidaxomicin acceptation aux états-unis
  • brilinta approval
  • fidaxomicin

 

More from our blog

See all posts
No Comments